| Literature DB >> 31826860 |
Michael J Ray1,2, Gregory B Tallman3, David T Bearden2, Miriam R Elman4, Jessina C McGregor2.
Abstract
OBJECTIVES: To identify the frequency with which antibiotics are prescribed in the absence of a documented indication in the ambulatory care setting, to quantify the potential effect on assessments of appropriateness of antibiotics, and to understand patient, provider, and visit level characteristics associated with antibiotic prescribing without a documented indication.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31826860 PMCID: PMC7190070 DOI: 10.1136/bmj.l6461
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Fig 1Derivation of analytic sample: weighted counts from 2015 National Ambulatory Medical Care Survey
Fig 2Seasonal trends for appropriateness of antibiotic prescribing. Rao-Scott χ2 test for differences in prescribing without indication, P=0.58. 37% of annual antibiotic prescriptions were in winter, 21% in spring, 18% in summer, and 24% in fall
Bivariable comparisons of patient, provider, and visit characteristics by indication type. Values are percentages (95% CI) unless stated otherwise
| Characteristics | Overall | Indication type | P value | ||
|---|---|---|---|---|---|
| Appropriate | Inappropriate | No indication | |||
| Overall proportion | - | 57 (52 to 62) | 25 (21 to 29) | 18 (15 to 22) | - |
|
| |||||
| Sex: | 0.54 | ||||
| Male | 61 (56 to 66) | 54 (48 to 60) | 29 (24 to 34) | 17 (12 to 22) | |
| Female | 39 (34 to 44) | 59 (52 to 65) | 23 (18 to 27) | 19 (15 to 23) | |
| Age, years: | <0.001 | ||||
| <18 | 21 (16 to 27) | 78 (72 to 84) | 13 (7 to 19) | 8 (5 to 11) | |
| 18-64 | 56 (50 to 63) | 56 (48 to 63) | 24 (19 to 29) | 20 (15 to 25) | |
| ≥65 | 22 (19 to 26) | 40 (32 to 47) | 38 (31 to 45) | 22 (16 to 28) | |
| Race/ethnicity: | 0.35 | ||||
| Non-Hispanic white | 58 (51 to 66) | 56 (51 to 62) | 25 (21 to 29) | 18 (14 to 23) | |
| Non-Hispanic black | 15 (11 to 18) | 50 (41 to 59) | 26 (18 to 33) | 24 (17 to 31) | |
| Hispanic | 19 (14 to 24) | 59 (50 to 68) | 27 (18 to 36) | 14 (8 to 19) | |
| Other non-Hispanic | 8 (2 to 14) | 67 (40 to 93) | 17 (2 to 33) | 16 (2 to 31) | |
| Payment type: | 0.26 | ||||
| Private insurance | 49 (43 to 54) | 62 (56 to 68) | 22 (18 to 27) | 16 (12 to 20) | |
| Medicare/Medicaid | 39 (34 to 45) | 48 (43 to 54) | 30 (26 to 35) | 21 (17 to 26) | |
| Self pay | 5 (1 to 8) | 74 (49 to 99) | 15 (0 to 30) | 11 (0 to 24) | |
| Other/missing | 7 (1 to 14) | 60 (41 to 78) | 20 (10 to 30) | 20 (10 to 31) | |
| Chronic disease: | 0.005 | ||||
| Yes | 56 (50 to 62) | 50 (43 to 56) | 29 (24 to 34) | 22 (17 to 27) | |
| No | 44 (38 to 50) | 66 (61 to 71) | 20 (16 to 24) | 14 (10 to 17) | |
|
| |||||
| Geographic region: | 0.92 | ||||
| West | 21 (15 to 27) | 63 (49 to 77) | 18 (11 to 26) | 19 (11 to 26) | |
| Midwest | 17 (13 to 22) | 56 (47 to 65) | 22 (17 to 26) | 17 (13 to 20) | |
| North east | 24 (17 to 31) | 48 (41 to 56) | 34 (27 to 42) | 17 (11 to 23) | |
| South | 38 (30 to 47) | 59 (51 to 68) | 22 (17 to 26) | 19 (12 to 26) | |
| Specialty category: | <0.001 | ||||
| Primary care | 60 (52 to 68) | 69 (64 to 75) | 18 (14 to 23) | 12 (9 to 16) | |
| Common antibiotic. prescribers | 14 (10 to 18) | 43 (38 to 49) | 32 (28 to 36) | 24 (18 to 31) | |
| All other specialties | 25 (19 to 32) | 35 (18 to 52) | 36 (24 to 48) | 29 (18 to 39) | |
| Ownership type: | 0.092 | ||||
| Physician or physician group | 77 (69 to 84) | 54 (48 to 61) | 27 (22 to 31) | 19 (15 to 24) | |
| Medical/academic center | 7 (3 to 11) | 62 (46 to 77) | 18 (7 to 28) | 21 (13 to 28) | |
| Insurance company/HMO/other | 16 (10 to 23) | 67 (59 to 75) | 21 (12 to 30) | 12 (7 to 17) | |
|
| |||||
| Primary care physician: | 0.004 | ||||
| Yes | 52 (44 to 59) | 70 (64 to 76) | 17 (13 to 20) | 14 (10 to 17) | |
| No | 47 (39 to 54) | 42 (34 to 51) | 34 (28 to 41) | 23 (17 to 29) | |
| Median time with provider, min: | 0.023 | ||||
| <17 | 48 (42 to 54) | 65 (59 to 72) | 20 (16 to 24) | 15 (11 to 19) | |
| ≥17 | 52 (46 to 58) | 49 (43 to 55) | 30 (24 to 35) | 21 (17 to 26) | |
| Culture taken: | <0.001 | ||||
| Yes | 11 (6 to 16) | 71 (60 to 82) | 24 (12 to 37) | 5 (1 to 9) | |
| No | 89 (84 to 94) | 55 (49 to 61) | 25 (21 to 29) | 20 (16 to 24) | |
| Antibiotic class: | <0.001 | ||||
| Cephalosporins | 12 (9 to 14) | 64 (53 to 75) | 16 (10 to 23) | 20 (12 to 27) | |
| Macrolides | 18 (12 to 23) | 67 (57 to 78) | 19 (11 to 26) | 14 (7 to 21) | |
| Miscellaneous | 9 (7 to 11) | 44 (35 to 54) | 32 (22 to 43) | 23 (16 to 31) | |
| Penicillins | 23 (19 to 26) | 72 (64 to 79) | 18 (12 to 23) | 11 (7 to 15) | |
| Quinolones | 20 (16 to 24) | 42 (32 to 52) | 38 (29 to 47) | 20 (13 to 28) | |
| Sulfonamides | 2 (0 to 3) | 32 (3 to 61) | 16 (1 to 31) | 52 (17 to 87) | |
| Tetracyclines | 7 (6 to 9) | 51 (41 to 62) | 30 (21 to 39) | 18 (10 to 26) | |
| Urinary anti-infectives | 4 (2 to 6) | 33 (21 to 45) | 33 (18 to 48) | 34 (21 to 47) | |
| Other | 5 (4 to 8) | 55 (44 to 67) | 25 (15 to 34) | 20 (9 to 31) | |
| Main reason for visit: | <0.001 | ||||
| New problem | 54 (49 to 59) | 71 (65 to 77) | 20 (16 to 24) | 9 (12 to 27) | |
| Chronic problem, routine | 19 (15 to 22) | 45 (33 to 57) | 29 (21 to 37) | 26 (16 to 36) | |
| Chronic problem, flare-up | 7 (4 to 10) | 50 (35 to 65) | 32 (23 to 42) | 18 (7 to 29) | |
| Pre-surgery | 2 (1 to 3) | 3 (0 to 5) | 68 (53 to 84) | 29 (14 to 44) | |
| Post-surgery | 8 (4 to 12) | 43 (30 to 56) | 37 (23 to 50) | 21 (9 to 32) | |
| Preventive care | 10 (7 to 12) | 31 (19 to 43) | 21 (13 to 29) | 49 (37 to 60) | |
HMO=health maintenance organization.
Rao-Scott χ2 P value for any (appropriate or inappropriate) versus no indication.
Includes gynecologists, dermatologists, urologists, and otolaryngologists.
Includes carbapenems, leprostatics, aminoglycosides, lincomycin derivatives, glycylcyclines, and glycopeptide antibiotics.
Fig 3Appropriateness of prescribing by class of antibiotic. *Includes carbapenems, leprostatics, aminoglycosides, lincomycin derivatives, glycylcyclines, and glycopeptide antibiotics
Adjusted odds ratios for association between significant independent predictors and antibiotic prescription without documented indication
| Predictors | Adjusted odds ratio |
|---|---|
| Age and sex: | |
| Males: ≥18 | 2.3 (1.02 to 5.3) |
| Females: ≥18 | 1.1 (0.6 to 2.2) |
| Chronic disease | 1.4 (0.95 to 2.2) |
| Specialty: | |
| Primary care | Reference |
| All other specialties | 2.1 (1.2 to 3.7) |
| Common prescribers | 1.9 (1.1 to 3.3) |
| Longer visit: ≥17 min | 1.6 (1.1 to 2.5) |
| Culture taken | 0.2 (0.1 to 0.4) |
| Antibiotic class: | |
| Penicillins | Reference |
| Cephalosporins | 1.6 (0.96 to 2.7) |
| Macrolides | 0.9 (0.4 to 2.1) |
| Miscellaneous | 1.6 (0.8 to 3.2) |
| Other | 1.3 (0.7 to 2.5) |
| Quinolones | 1.5 (0.8 to 2.7) |
| Sulfonamides | 4.9 (1.5 to 15.7) |
| Tetracyclines | 1.3 (0.6 to 2.7) |
| Urinary anti-infectives | 3.1 (1.3 to 7.6) |
Adjusted for age, sex, geographic region, and pre-surgery visit.
Includes specialists in gynecology, urology, dermatology, and otolaryngology.
Includes carbapenems, leprostatics, aminoglycosides, lincomycin derivatives, glycylcyclines, and glycopeptide antibiotics.